Macrolide's Anti-Inflammatory Effects on Acute and Subacute Inflammation (Azithromycin, Clarithromycin, and Roxithromycin)

Macrolide's Anti-Inflammatory Effects on Acute and Subacute Inflammation (Azithromycin, Clarithromycin, and Roxithromycin)

Vandana M. Thorat, Mahesh Manohar Bharambe
Copyright: © 2023 |Pages: 16
DOI: 10.4018/979-8-3693-1301-5.ch018
OnDemand:
(Individual Chapters)
Available
$37.50
No Current Special Offers
TOTAL SAVINGS: $37.50

Abstract

The key characteristics of acute inflammation are the exudation of fluid and plasma proteins and the emigration of leukocytes, mostly neutrophils, and it often begins within minutes or hours in response to infection and tissue damage and lasts for many hours. After the harmful agents have been removed, the acute inflammatory response fades, but if the response fails to eradicate the stimuli, the reaction might develop into a prolonged phase referred to as chronic inflammation. Since there is no safe, effective anti-inflammatory drug, scientists continue to study inflammation. Azithromycin, Clarithromycin, and Roxithromycin were tested for anti-inflammatory properties in Wistar rats with acute and sub-acute inflammation. Karad's largest animal house supplied 200–300g Wistar rats. Before the studies, the animals were used to the 24-hour cycle of light and dark for ten days. There was generally enough water and rat pellets. The IAC authorised this study (Institutional Animal Ethics Committee).
Chapter Preview
Top

1. Introduction

Despite the availability of safer and more potent anti-inflammatory agents, research into inflammation remains a hot topic. Inflammation is a multifaceted and ever-changing state characterised by a cascade of molecular and cellular responses aimed at eliminating harmful invaders and repairing or replacing compromised tissue. Patients often seek medical care for relief from pain and inflammation (Chensue & Ward, 1990). Inflammation is a complicated response in tissues which consists mostly of reactions of blood vessels and leukocytes, and which serves primarily as a defensive response (Fernandes, et al., 2017).

Inflammation is a factor that is shared by a number of conditions, including bronchial asthma, chronic obstructive pulmonary disease, chronic sinusitis, bronchiolitis, cystic fibrosis, uveitis, autoimmune illnesses, rheumatoid arthritis, and ankylosing spondylitis (Gosavi, et al., 2015). The implicated inflammatory processes are to blame for the hypersensitive reactions, which can be lethal at times and are triggered by things like insect stings, toxins, and drugs (Vashishtha, 2019). These ailments are all extremely debilitating and restricting in some way. The plasma proteins, the circulating leukocytes (white blood cells), and the tissue phagocytes that are formed from the circulating cells are the basic types of defences that the body possesses (Scaglione and Rossoni, 1998). This is achieved by the concerted efforts of the vascular system, the leukocytes, and the plasma proteins (Munshi, et al., 2019). Inflammatory reactions at the cellular and vascular levels are triggered by soluble components obtained from plasma proteins that are activated or created in response to an inflammatory stimulus. These proteins are activated when an inflammatory stimulus is present (Ratzinger, et al., 2014).

Acute inflammation is characterised by several key features, the most important of which are the discharge of fluid and plasma proteins as well as the emigration of leukocytes, most of which are neutrophils (Munshi, et al., 2022). This type of inflammation typically begins within minutes or hours as a response to tissue injury or infection and can continue for many hours. However, if the response does not eradicate the stimulus, the response may evolve into a prolonged phase known as chronic inflammation, which continues long after the acute phase has ended. This phase of the response is known to endure for a very long time (Winter, et al., 1962). Chronic inflammation is characterised by an inflammatory response that lasts for an extended period of time and includes the proliferation of blood vessels, the presence of lymphocytes and macrophages, the formation of fibrosis, and the destruction of healthy tissue. Chronic inflammation is associated with more tissue damage and a longer duration of inflammation. Chronic inflammation is characterised by an inflammatory response that lasts for an extended period of time (Vashishtha & Sherman, 2018). Innate immunity, which includes acute inflammation, and adaptive immunity, which also includes chronic inflammation, are in the forefront when it comes to the methods that the host uses to defend itself (Mahdi, et al., 2006).

When the trigger is removed, inflammation stops. Short half-lives of leukocytes in tissues facilitate the breakdown and dissipation of mediators, bringing relief to the inflammatory response. Anti-inflammatory systems are activated to help regulate the host’s reaction and limit any potential harm (Munshi, et al., 2018). As soon as the inflammatory response has eliminated the harmful stimuli, the tissue healing process may begin. During the healing process, damaged tissue is replaced by newly regenerated, healthy cells, and any remaining flaws are filled up by connective tissue (scarring) (Shinkai, et al., 2008).

Complete Chapter List

Search this Book:
Reset